Off-label marketing: the competition for “biggest corporate fine” gets juicy

It is so important to admit when you're wrong. So here goes... When I wrote that Astra-Zeneca paid the biggest corporate fine in American history ($520 million) for the off-label marketing of Seroquel, an atypical antipsychotic [I wrote that here]; I was wrong. (NOTE: off-label marketing is the promotion of a drug - whether amongst patients, doctors, or other... Continue Reading →

March 11, 2011

December 2023
M	T	W	T	F	S	S
	1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

function wpb_rand_posts() { 
 
$args = array(
    'post_type' => 'post',
    'orderby'   => 'rand',
    'posts_per_page' => 5, 
    );
 
$the_query = new WP_Query( $args );
 
if ( $the_query->have_posts() ) {
 
$string .= '<ul>';
    while ( $the_query->have_posts() ) {
        $the_query->the_post();
        $string .= '<li><a href="'. get_permalink() .'">'. get_the_title() .'</a></li>';
    }
    $string .= '</ul>';
    /* Restore original Post Data */
    wp_reset_postdata();
} else {
 
$string .= 'no posts found';
}
 
return $string; 
} 
 
add_shortcode('wpb-random-posts','wpb_rand_posts');
add_filter('widget_text', 'do_shortcode');

Up ↑

Tag: Eli Lilly & Co.

Off-label marketing: the competition for “biggest corporate fine” gets juicy

Like this:

Categories

Subscribe to Blog via Email